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Abstract: The aim of this study was to characterize the phenolic composition and evaluate the
bioactivity of several samples of Lavandula pedunculata (Mill.) Cav, and to compare aqueous and
hydroethanolic extracts. Plant materials were obtained by growing some accessions (seed samples)
of various wild populations from different regions of Portugal conserved at the Portuguese
Genebank in Braga. Phenolic compounds were analised by HPLC-DAD-ESI/MSn, antioxidant
potential through in vitro assays (DPPH radical scavenging activity, reducing power and inhibition
of lipid peroxidation), cytotoxicity on tumor cells (MCF-7, NCI-H460, HeLa and HepG2) and
non-tumor (PLP2) cells, anti-inflammatory activity in rat RAW 264.7 macrophages, by the ability
to inhibit NO production and antimicrobial potential by the microdilution method with INT dye
(iodonitrotetrazolium chloride). Thirteen compounds were identified, being salvianolic acid B,
rosmarinic acid and luteolin-7-O-glucuronide, the main compounds present, with values ranging
between 44.3–582, 50.9–550, and 24.36–101.5 mg/g extract, respectively. L. pedunculata aqueous
extract revealed a higher antioxidant potential (EC50 values between 14 to 530 µg/mL), which
could be related to its higher concentration in phenolic compounds; however, the hydroethanolic
extract showed a higher anti-inflammatory (lower EC50 values than 124 µg/mL) potential and
antiproliferative capacity (lower GI50 values than 34 µg/mL). Thus, this study highlights the bioactive
effects of this species and opens up possibilities of uses in food and pharmaceutical formulations.
However, there are potential differences in such properties according to geographical origin of plant
material, as in general, the samples from Alentejo presented higher results in all the bioactivities,
compared with Trás-os-Montes samples.
Keywords: phenolic composition; antioxidant activity; antimicrobial activity; antiproliferative effect;
Lavandula pedunculata (Mill.) Cav
1. Introduction
Bioactive compounds are molecules that have health benefits on living organisms, tissues or cells,
being comprised of a wide range of classes, such as vitamins, carotenoids (lycopene, β-carotene and
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xanthophylls) and phenolic compounds [1]. These compounds are present in a wide range of foods
(e.g., fruits, vegetables, plants and other food products) and its ingestion enables the induction of
positive effects in the prevention and treatment of many human diseases, such as anxiety, insomnia,
anorexia, cough and bronchitis [2].
Throughout the years, phenolic compounds have been largely studied in several foods, namely
edible plants, due to their therapeutic capabilities in pathologies related to the nervous and
gastrointestinal systems [3]; they also exhibit antioxidant, antitumor, anti-inflammatory and antiviral
properties [1]. These molecules are characterized by being a very heterogeneous group of a great
variety of compounds, such as phenolic acids, coumarins, flavonoids, stilbenes, hydrolysable and
condensed tannins, lignans and lignins [3,4]. Flavonoids are one of the most abundant groups
within phenolic compounds; their main mechanism of action goes through their ability of capturing
reactive oxygen species and chelate metal ions, having a distinct antioxidant action [4]. Thus, the
ingestion of antioxidants can significantly control the severity of chronic diseases, providing a close
relationship between the uptake of free radicals and the involvement of endocrine responses. Therefore,
the inclusion of antioxidants in the diet for the prevention of chronic diseases and for an improvement
of general health, has been an important research target in recent decades [5].
Lavandula pedunculata (Mill.) Cav. (common English name French lavender and known in Portugal
as rosmaninho, arçã, rosmaninho maior or lavanda), is a species belonging to the Lamiaceae which
is native to the Iberian Peninsula, North Africa and Turkey [6–8]. In the Iberian Peninsula, this
species has a widespread distribution and significant ethnobotanical uses documented [6,9]. It is
considered the most resistant of all species of the Lavandula genus, well adapted to continental climates,
especially to annual variation in temperature (hot summers and cold winters), growing in altitudes up
to 1700 m [6,9]. In the context of traditional medicine, L. pedunculata has been used in infusions for
internal and external applications, mainly recommended for the respiratory and digestive systems and
as a therapeutic agent with antiseptic action for cleaning wounds [6,10].
Wild plant genetic resources, particularly of medicinal and aromatic species, have received
increased interested worldwide. Besides L. pedunculata traits and potential use in different domains
(e.g., as source of bioactive compounds), this endemic species had poor representation in germplasm
collections and has not been comprehensively characterized [8]. Therefore, the Portuguese Genebank
(BPGV) carried out in 2009, several collecting missions of Lavandula germoplasm in different regions
of the national territory, including L. pedunculata [8]. The main purpose was to collect plant diversity,
promoting ex situ conservation and providing morphological, molecular, chemical, and biochemical
information (germplasm characterization); the seeds of several wild populations (genebank accessions)
were stored at the BPGV facilities, in Braga, Portugal [8].
As bioactive molecules are often produced in response to changes in the surrounding environment,
the same plant species growing at different sites may have different concentrations of the most
promising compounds, or even different compounds in their constitution [11]. Germplasm accessions
conserved at genebanks might generate very good matrices to evaluate useful characteristics and
bioactive properties, because they correspond to stored plant materials of the same species but of
different provenance. Moreover, genebanks procedures, such as germplasm characterization, provide
the description of plant germplasm and determine the expression of highly heritable characters ranging
from morphological, agronomical, chemical features to bioactive properties or molecular markers.
The aim of the present study was to evaluate the phenolic profile of the hydroethanolic and
aqueous extracts of thirteen Lavandula pedunculata (Mill.) Cav. samples, whose seeds originated from
different regions of Portugal, and are conserved ex-situ in the Portuguese Genebank. The bioactive
properties were explored in terms of antioxidant, anti-inflammatory, cytotoxicity and antimicrobial
potential. Furthermore, the study also addressed L. pedunculata germoplasm characterization
(e.g., chemical and biochemical characteristics), contributing with relevant data about the studied
accessions, enabling eventual discrimination among them, resulting in better insight about the
composition of the germplasm collection and its genetic diversity.
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2. Results
2.1. Phenolic Compounds
Data related to the phenolic compounds identification (retention time, λmax in the visible
region, molecular ion, main fragment ions in MS2, and tentative identification) obtained by
HPLC-DAD-ESI/MSn analysis of Lavandula pedunculata (Mill.) Cav. samples are presented in
Table 1. All samples presented a similar profile (Figure 1), revealing the presence of thirteen phenolic
compounds, in both hydroethanolic and aqueous extracts, being nine identified as phenolic acids
(mainly caffeic acid dimers, trimers and tetramers) and four flavonoids (mainly luteolin and eriodictyol
glycoside derivatives).
Caffeic acid (compound 4), luteolin-7-O-glucuronide (compound 8) and rosmarinic acid
(compound 10) were positively identified by comparison with commercial standards. Rosmarinic acid
has been one of the main compounds previously identified in Lavandula species [3,12–15]. Compounds
1 and 2, 3 and 7 were identified as caffeic, p-coumaric and rosmarinic acid hexosides, based on the
respective fragment ions released at m/z 179 [caffeic acid-H]−, 163 [coumaric acid-H]− and 359
[rosmarinic acid-H]− after loss of a hexosyl moiety (−162 mu). With the exception of rosmarinic acid
hexoside, the mentioned compounds have been found in Lavandula x intermedia Emeric ex Loiseleur)
Waste [12].
Compound 9 ([M − H]− at m/z 719) released a main MS2 fragment at m/z 359 ([M − 2H]2−,
rosmarinic acid), which allowed its identification as sagerinic acid [16]. Compound 11 ([M − H]− at
m/z 537) presented a similar UV spectrum and fragmentation pattern, consistent with the caffeic acid
trimer lithospermic acid A [16–18]. Other identities, with the same molecular weight (salvianolic acids
H/I), were discarded because they present quite a different fragmentation pattern [18,19]. Thus, being
assigned to lithospermic acid A. Compound 13 ([M − H]− at m/z 717) presented a fragmentation
pattern with successive losses of 198 mu (danshensu) or 180 mu (caffeic acid) units, coherent with
salvianolic acid B (also known as lithospermic acid B) [18,19]. These compounds have not been
previously identified in Lavandula species, to the best of the authors’ knowledge.
The remaining compounds correspond to glycosylated flavones. Compound 5 ([M − H]− at m/z
623) MS2 fragments revealed the alternative loss of hexosyl (m/z at 461; −162 u) and glucuronyl (m/z
at 285; −176 u) residues, indicating location of each residue on different positions of the aglycone.
No information about the identity of the sugar moieties and location on the aglycone could be
obtained, so, the compound was identified as luteolin-O-hexosyl-O-glucuronide [20]. Compound
6 ([M − H]− at m/z 463) was identified as a eriodictyol derivative, due to its UV-Vis spectra and
MS fragmentation. This peak revealed the loss of glucuronyl (−176 u), therefore being assigned as
eriodictyol-O-glucuronide [21]. Compound 12 ([M − H]− at m/z 623) presented 42 u higher then
compound 8, thus being assigned to methylluteolin-O-glucuronide [21]. Also, to the best of our
knowledge, these compounds have not been previously identified in Lavandula species.
In a previous study performed by Costa et al. [3], using polar extracts from Lavandula
pedunculata subsp. lusitanica, six different phenolic compounds were detected (3-O-caffeoylquinic acid,
4-O-caffeoylquinic acid, 5-O-caffeoylquinic acid, rosmarinic acid, luteolin and apigenin), nonetheless,
only rosmarinic acid was the common phenolic acid identified, but revealed smaller amounts. However,
also in this case, this compound proved to be the majority, in the hydroethanolic and ethanolic extracts.
The differences observed between the different samples could be explained, due to the influence
that the geographical area has on the chemical composition of plants, namely at the level of soil
composition, climacteric environment, air humidity and daily sun exposure [11]. Moreover, to the best
of the authors’ knowledge, and with the exception of the previous mentioned authors, there are no
more reports describing the phenolic composition of L. pedunculata (Mill.) Cav.
Molecules 2018, 23, 1037 4 of 19
Molecules 2018, 23, x 4 of 19 
 
 
Figure 1. Chromatographic profile of sample 3 (Vila Viçosa, Évora) recorded at 280 nm, the peak numbers correspond to the compounds listed in Table 1. 
Table 1. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data and tentative identification of phenolic 
compounds in L. pedunculata samples. 
Peak Rt (min) λmax (nm) [M-H]− (m/z) MS2 (m/z) Tentative Identification Identification Type 
1 5.97 320 341 179(100) Caffeic acid hexoside [12], DAD/MS 
2 6.57 320 341 179(100) Caffeic acid hexoside [12], DAD/MS 
3 8.65 310 325 163(100) p-Coumaroyl hexoside [12], DAD/MS 
4 10.16 320 179 119(100) Caffeic acid Standard/DAD/MS 
5 13.22 332 623 461(27), 285(100) Luteolin-O-hexosyl-O-glucuronide [20], DAD/MS 
6 16.34 284,330 sh 463 287(100) Eriodictyol-O-glucuronide [21], DAD/MS 
7 17.64 320 521 359(100), 197(8), 179(14), 161(3), 135(5) Rosmarinic acid hexoside [22], DAD/MS 
8 18.68 347 461 285(100) Luteolin-7-O-glucuronide Standard/DAD/MS 
9 19.23 283,338 sh 719 539(29), 521(18), 359(100), 179(32), 161(5), 135(5) Sangerinic acid [16], DAD/MS 
10 22.29 325 359 197(27), 179(37), 161(100), 135(5) Rosmarinic acid  Standard/DAD/MS 
11 23.19 288,328 sh 537 493(18), 359(100), 313(11), 295(5), 197(3), 179(3) Lithospermic acid A [17–19], DAD/MS 
12 24.65 340 475 299(100), 284(68) Methylluteolin-O-glucuronide [21], DAD/MS 
13 25.75 309,338sh 717 537(47), 519(17), 493(40), 359(97), 339(10), 321(8), 313(17), 295(100), 197(7), 179(27) Salvianolic acid B [18,19], DAD/MS 
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 50 52 54 56 58 60 
Tempo (min) 
0 
200000
400000
600000
800000
1000000
1200000
1400000
1600000
1 2 3 4 
5 6 
7 
8 
9 
10 
11 
12 
13 
Figure 1. Chromatographic profile of sample 3 (Vila Viçosa, Évora) recor e , t e peak numbers correspond to the compound listed in Table 1.
Table 1. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data and tentative identification of phenolic compounds
in L. pedunculata samples.
Peak Rt (min) λmax (nm) [M-H]− (m/z) MS2 (m/z) Tentative Identification Identification Type
1 5.97 320 341 179(100) Caffeic acid hexoside [12], DAD/MS
2 6.57 320 341 179(100) Caffeic acid hexoside [12], DAD/MS
3 8.65 310 325 163(100) p-Coumaroyl hexoside [12], DAD/MS
4 10.16 320 179 119(100) Caffeic acid Standard/DAD/MS
5 13.22 332 623 461(27), 285(100) Luteolin-O-hexosyl-O-glucuronide [20], DAD/MS
6 16.34 284,330 sh 463 287(100) Eriodictyol-O-glucuronide [21], DAD/MS
7 17.64 320 521 359(100), 197( ), 179(14), 161(3), 135(5) Rosmarinic acid hexoside [22], DAD/MS
8 18.68 347 461 285(100) Luteolin-7-O-glucuronide Standard/DAD/MS
9 19.23 283,338 sh 719 539(29), 521(18), 359(100), 179(32), 161(5), 135(5) Sangerinic acid [16], DAD/MS
10 22.29 325 359 197(27), 179(37), 161(100), 135(5) Rosmarinic acid Standard/DAD/MS
11 23.19 288,328 sh 537 493(18), 359(100), 313(11), 2 5(5), 197(3), 179(3) Lithospermic acid A [17–19], DAD/MS
12 24.65 340 475 299(100), 284(68) Methylluteolin-O-glucuronide [21], DAD/MS
13 25.75 309,338sh 717 537(47), 519(17), 493(40), 359(97), 339(10), 321(8), 313(17),295(100), 197(7), 179(27) Salvianolic acid B [18,19], DAD/MS
Molecules 2018, 23, 1037 5 of 19
Phenolic acids represent a significant part of this phenolic profile (Table 2), highlighting salvianolic
acid B (compound 13) and rosmarinic acid (compound 10) as the major phenolic compounds present
in both types of extracts. Regarding flavonoids, luteolin-7-O-glucuronide (compound 8) was the main
compound present (Table 2). In general, the aqueous extract revealed the highest content in phenolic
compounds, revealing sample 8 (Ponte de Sôr, Portalegre) the highest concentration in total phenolic
acids, flavonoids and total phenolic compounds for both the studied extracts. This difference could
be explained to the chemical composition that each of the seeds initially presented and due to their
different geographic origin.
2.2. Antioxidant Potential
The antioxidant activity of L. pedunculata hydroethanolic and aqueous extracts was evaluated
using different in vitro assays (DPPH radical-scavenging activity, reducing power, inhibition of
β-carotene bleaching and inhibition of lipid peroxidation—TBARS) and the results are present in
Table 3. All samples, for both of the studied extracts, revealed antioxidant potential, EC50 values
between 530–14 µg/mL and 1833–17 µg/mL for aqueous and hydroethanolic extract, respectively.
In general, there is not a large divergence regarding EC50 values between the hydroethanolic and
aqueous extracts. Accordingly, for aqueous extracts, sample 4 (Bragança) revealed the highest DPPH
scavenging activity (EC50 = 68.0 µg/mL), while sample 2 (Évora) revealed the highest reducing power
(EC50 = 51 µg/mL). For the β-carotene bleaching inhibition assay, samples 2 (Évora) and 10 (Castelo
de Vide, Portalegre), with values of 253 and 236 µg/mL, respectively, revealed the highest potential.
On the other hand, sample 1 (Marvão, Portalegre) revealed the highest antioxidant potential for the
TBARS inhibition assay (14 µg/mL).
Otherwise, hydroethanolic extracts of samples 10 (Castelo de Vide, Portalegre), 11 (Elvas,
Portalegre), 12 (Castelo de Vide, Portalegre), and 13 (Bragança) showed the lowest EC50 values for the
β-carotene bleaching inhibition assay, presenting values of 252, 190, 223 and 214 µg/mL, respectively.
Additionally, in the hydroethanolic extracts, samples 8 (Ponte de Sôr, Portalegre), 9 (Évora), and 2
(Évora) showed the highest antioxidant capacity for the DPPH scavenging activity, reducing power
and TBARS inhibition assays, respectively. The highest EC50 values (lowest antioxidant activity)
were detected in sample 13 (Bragança) for DPPH scavenging activity (257 µg/mL) and reducing
power (216 µg/mL), in sample 8 for β-carotene bleaching inhibition (1833 µg/mL), and in samples 6
(Portalegre) and 11 (Elvas, Portalegre) in TBARS inhibition (63.5 and 62 µg/mL, respectively).
These results are in agreement with those found by Costa et al. [3], where the antioxidant potential
L. pedunculata was evaluated by TBARS assay and at the highest concentration tested (5 mg/mL), the
infusion, water and water:ethanol extracts completely prevented MDA production.
In a study performed by Pereira et al. [15], the antioxidant activity of different extracts (n-hexane,
dichloromethane, ethyl acetate, methanol and water) of L. pedunculata was evaluated regarding the
lipid peroxidation index (%), obtaining values that ranged from 26 to 41%. Moreover, Ferreira et al. [23]
tested the ethanolic extracts and decoctions of L. pedunculata using the DPPH and β-carotene inhibition
methods, in which these samples revealed antioxidant activity, presenting values between 93 and
20 mg/mL, respectively. Baptista et al. [24], also studied the antioxidant potential for the essential oils
and extracts of two native Portuguese Lavandula species (L. stoechas subsp. luisieri and L. pedunculata)
and considering the results obtained, there is some similarity in the results of the methanolic and
aqueous extract, in comparison with the concentrations obtained in our study.
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Table 2. Phenolic compounds quantification (mg/g of extract, mean ± SD) in L. pedunculata hydroethanolic and aqueous extracts.
1 2 3 4 5 6 7 8 9 10 11 12 13
Hydroethanol Extract
Peak 1 0.28 ± 0.01 f 0.034 ± 0.003 k 0.179 ± 0.001 i tr 0.210 ± 0.005 h 0.23 ± 0.01 g 0.11 ± 0.04 j 2.44 ± 0.02 a 0.37 ± 0.01 d 0.44 ± 0.01 c 0.277 ± 0.004 f 0.59 ± 0.02 b 0.33 ± 0.02 e
Peak 2 0.18 ± 0.02 h 0.079 ± 0.003 j 0.31 ± 0.001 d 0.120 ± 0.003 i 0.22 ± 0.02 g 0.295 ± 0.001 e 0.24 ± 0.01 f 1.87 ± 0.02 a 0.40 ± 0.01 c 0.31 ± 0.02 de 0.22 ± 0.01 fg 0.54 ± 0.02 b 0.115 ± 0.001 i
Peak 3 0.77 ± 0.01 f 1.002 ± 0.001 d 0.80 ± 0.002 f 0.50 ± 0.01 h 0.95 ± 0.02 e 0.98 ± 0.01 de 1.48 ± 0.03 a 1.27 ± 0.07 b 1.16 ± 0.03 c 0.98 ± 0.03 de 0.80 ± 0.01 f 1.26 ± 0.01 b 0.57 ± 0.03 g
Peak 4 0.63 ± 0.02 i 0.805 ± 0.002 f 0.88 ± 0.001 d 0.639 ± 0.002 hi 1.01 ± 0.02 c 0.85 ± 0.02 e 1.14 ± 0.02 b 1.49 ± 0.03 a 1.00 ± 0.04 c 0.802 ± 0.001 f 0.72 ± 0.03 g 1.12 ± 0.04 b 0.65 ± 0.02 h
Peak 5 2.05 ± 0.03 f 2.33 ± 0.03 c 2.68 ± 0.01 b 1.37 ± 0.01 k 1.846 ± 0.001 g 1.84 ± 0.01 g 1.599 ± 0.004 i 1.54 ± 0.01 j 2.22 ± 0.01 d 2.695 ± 0.003 a 2.09 ± 0.01 e 2.06 ± 0.01 f 1.698 ± 0.003 h
Peak 6 0.137 ± 0.003 h tr 0.40 ± 0.01 c 0.74 ± 0.01 b 0.082 ± 0.003 i tr 0.060 ± 0.001 j 0.782 ± 0.003 a tr 0.299 ± 0.005 d 0.150 ± 0.003 g 0.231 ± 0.004 e 0.17 ± 0.01 f
Peak 7 1.18 ± 0.01 g 1.379 ± 0.001 de 1.52 ± 0.01 b 0.93 ± 0.02 i 1.40 ± 0.05 cd 1.355 ± 0.004 ef 1.39 ± 0.04 cde 1.78 ± 0.06 a 1.51 ± 0.09 b 1.32 ± 0.01 f 1.38 ± 0.05 de 1.43 ± 0.03 c 1.047 ± 0.002 h
Peak 8 13.10 ± 0.01 l 19.93 ± 0.02 e 21.68 ± 0.03 c 22.35 ± 0.06 b 12.15 ± 0.02 m 17.37 ± 0.02 i 18.62 ± 0.01 g 20.66 ± 0.01 d 19.7 ± 0.1 f 15.60 ± 0.02 k 17.57 ± 0.01 h 16.54 ± 0.02 j 24.36 ± 0.04 a
Peak 9 1.99 ± 0.01 e 2.34 ± 0.05 c 2.25 ± 0.04 d 2.90 ± 0.01 a 1.77 ± 0.08 g 1.97 ± 0.01 ef 2.38 ± 0.03 bc 2.4 ± 0.1 b 2.84 ± 0.08 a 2.20 ± 0.05 d 1.93 ± 0.01 f 1.13 ± 0.04 i 1.41 ± 0.03 h
Peak 10 21.4 ± 0.40 j 34.4 ± 0.4 e 38.5 ± 0.60 b 16.9 ± 0.5 k 36.0 ± 0.2 c 32.5 ± 0.6 f 26.11 ± 0.05 h 50.9 ± 0.9 a 30.4 ± 0.4 g 35.2 ± 0.6 d 23.5 ± 0.2 i 17.0 ± 0.6 k 7.5 ± 0.2 l
Peak 11 2.89 ± 0.01 k 4.27 ± 0.06 f 5.4 ± 0.4 c 4.00 ± 0.09 gh 3,52 ± 0.08 j 3.546 ± 0.002 ij 3.69 ± 0.09 i 6.4 ± 0.1 a 5.15 ± 0.04 d 4.4 ± 0.1 e 3.95 ± 0.1 h 4.1 ± 0.6 fg 6.0 ± 0.01 b
Peak 12 2.520 ± 0.001 i 2.73 ± 0.02 h 5.09 ± 0.02 a 3.57 ± 0.01 c 1.78 ± 0.01 k 2.41 ± 0.01 j 2.76 ± 0.02 g nd 3.14 ± 0.01 f 2.41 ± 0.01 j 5.06 ± 0.01 b 3.41 ± 0.03 e 3.52 ± 0.001 d
Peak 13 20.2 ± 0.50 h 36.8 ± 0.3 b 30.9 ± 0.5 d 14.89 ± 0.04 j 30.27 ± 0.04 e 30.9 ± 0.8 d 29.8 ± 0.4 f 44.3 ± 0.2 a 34.1 ± 0.5 c 30.6 ± 0.4 de 25.9 ± 0.4 g 16.7 ± 0.5 i 8.7 ± 0.01 k
TPA 50 ± 1 h 81 ± 1 b 81 ± 2 b 40.8 ± 0.4 j 75.4 ± 0.3 d 72.6 ± 0.2 e 66 ± 1 f 113 ± 1 a 77 ± 1 c 76.351 ± 0.003 c 59 ± 1 g 43.97 ± 0.04 i 26.3 ± 0.5 k
TF 17.81 ± 0.01 l 25.0 ± 0.01 e 29.85 ± 0.03 a 28.04 ± 0.04 c 15.86 ± 0.03 m 21.62 ± 0.01 j 23.04 ± 0.01 g 22.988 ± 0.002 h 25.1 ± 0.1 d 21.00 ± 0.02 k 24.86 ± 0.01 f 22.2 ± 0.1 i 29.75 ± 0.02 b
TPC 68 ± 1 k 106 ± 1 c 111 ± 2 b 68.9 ± 0.5 i 91.3 ± 0.3 g 94.2 ± 0.2 f 89 ± 1 h 136 ± 1 a 102 ± 1 d 97.36 ± 0.02 e 84 ± 1 i 66.17 ± 0.02 l 56.1 ± 0.5 m
Aqueous Extract
Peak 1 1.18 ± 0.06 d 0.87 ± 0.04 g 1.02 ± 0.02 e 0.59 ± 0.02 h 1.31 ± 0.01 b 1.20 ± 0.06 cd 1.23 ± 0.01 c 7.9 ± 0.1 a 1.19 ± 0.06 d 0.91 ± 0.05 fg 0.96 ± 0.04 f 1.02 ± 0.05 e 0.28 ± 0.04 i
Peak 2 2.36 ± 0.02 h 1.97 ± 0.04 j 2.65 ± 0.01 f 2.55 ± 0.08 g 2.31 ± 0.01 hi 3.8 ± 0.1 c 3.83 ± 0.03 c 5.03 ± 0.07 a 2.37 ± 0.05 h 2.28 ± 0.05 i 4.3 ± 0.01 b 3.19 ± 0.03 d 3.06 ± 0.08 e
Peak 3 3.5 ± 0.1 d 3.18 ± 0.03 g 3.002 ± 0.002 h 1.52 ± 0.06 l 3.22 ± 0.02 f 3.83 ± 0.02 c 4.19 ± 0.06 a 4.13 ± 0.03 b 2.98 ± 0.04 h 3.30 ± 0.03 e 2.77 ± 0.08 j 2.19 ± 0.09 k 2.90 ± 0.05 i
Peak 4 3.25 ± 0.006 f 3.46 ± 0.08 e 2.917 ± 0.004 h 2.80 ± 0.03 i 3.29 ± 0.04 f 3.14 ± 0.08 g 3.99 ± 0.08 b 3.87 ± 0.05 c 3.18 ± 0.04 g 2.80 ± 0.04 i 2.61 ± 0.05 j 3.63 ± 0.01 d 4.35 ± 0.04 a
Peak 5 6.49 ± 0.02 c 6.71 ± 0.02 b 8.76 ± 0.01 a 3.681 ± 0.003 k 5.18 ± 0.04 f 5.28 ± 0.01 d 4.1 ± 0.10 i 4.45 ± 0.02 g 3.32 ± 0.02 l 3.79 ± 0.01 j 4.34 ± 0.01 h 2.95 ± 0.03 m 5.22 ± 0.03 e
Peak 6 12.83 ± 0.04 d 9.36 ± 0.02 h 8.87 ± 0.03 i 16.73 ± 0.04 a 8.6 ± 0.1 k 10.8 ± 0.1 g 11.6 ± 0.10 f 12.9 ± 0.1 d 8.17 ± 0.02 l 12.97 ± 0.04 c 13.31 ± 0.05 b 8.8 ± 0.1 j 12.26 ± 0.02 e
Peak 7 2.52 ± 0.01 cd 2.41 ± 0.09 e 3.33 ± 0.01 a 1.6 ± 0.2 h 2.45 ± 0.08 de 2.26 ± 0.04 f 2.38 ± 0.07 e 2.83 ± 0.01 b 2.61 ± 0.03 c 3.3 ± 0.2 a 2.16 ± 0.09 g 2.74 ± 0.01 b 2.11 ± 0.06 g
Peak 8 70.81 ± 0.04 g 64.31 ± 0.02 k 76.4 ± 0.1 d 101.5 ± 0.1 a 42.12 ± 0.01 m 66.8 ± 0.1 i 65.9 ± 0.1 j 84.1 ± 0.1 c 73.56 ± 0.09 f 67.35 ± 0.08 h 73.8 ± 0.1 e 53.6 ± 0.2 l 99.43 ± 0.02 b
Peak 9 4.4 ± 0.1 ef 3.26 ± 0.03 i 4.4 ± 0.4 ef 6.6 ± 0.1 a 3.73 ± 0.03 h 4.3 ± 0.5 g 4.6 ± 0.1 e 5.2 ± 0.1 d 6.2 ± 0.5 b 5.7 ± 0.4 c 3.30 ± 0.01 i 4.3 ± 0.30 g 5.8 ± 0.3 c
Peak 10 290.0 ± 0.4 e 293 ± 3 d 353.0 ± 0.3 b 190 ± 2 j 288.6 ± 0.2 f 318.0 ± 0.7 c 211 ± 1 i 550 ± 3 a 266.3 ± 0.7 g 291 ± 4 e 218.4 ± 0.5 h 52.2 ± 0.6 k 27.1 ± 0.3 l
Peak 11 11.5 ± 0.3 i 13.9 ± 0.4 g 16.37 ± 0.06 c 15.1 ± 0.4 d 9.8 ± 0.3 j 12.2 ± 0.6 h 9.63 ± 0.02 j 16.8 ± 0.2 b 14.83 ± 0.07 de 14.7 ± 0.4 e 14.14 ± 0.09 f 16.9 ± 0.1 b 26.2 ± 0.6 a
Peak 12 11.25 ± 0.03 e 7.75 ± 0.02 j 16.08 ± 0.01 b 15.1 ± 0.1 c 4.45 ± 0.04 k 8.54 ± 0.04 i 8.9 ± 0.1 h nd 10.9 ± 0.1 f 8.51 ± 0.02 i 19.8 ± 0.1 a 9.73 ± 0.02 g 13.7 ± 0.1 d
Peak 13 381 ± 5 d 390 ± 2 c 366.7 ± 0.9 e 212.9 ± 0.4 k 309.9 ± 0.4 h 405 ± 3 b 279 ± 2 j 582 ± 1 a 343 ± 2 f 340 ± 4 g 305.7 ± 0.5 i 62.8 ± 0.3 l 47.7 ± 0.8 m
TPA 699 ± 5 d 712 ± 1 c 753.4 ± 0.7 b 433 ± 3 j 621.6 ± 0.8 g 754 ± 3 b 519 ± 3 i 1177 ± 3 a 643 ± 2 f 664 ± 9 e 554.3 ± 0.1 h 148.9 ± 0.6 k 119 ± 1 l
TF 101.4 ± 0.2 e 88.13 ± 0.05 j 110.06 ± 0.01 d 137.0 ± 0.2 a 60.3 ± 0.1 l 91.4 ± 0.1 h 90.4 ± 0.2 i 101.4 ± 0.2 e 96.0 ± 0.2 f 92.6 ± 0.1 g 111.2 ± 0.1 c 75.1 ± 0.3 k 130.6 ± 0.2 b
TPC 801 ± 5 d 801 ± 1 d 863.5 ± 0.7 b 570 ± 3 j 681.9 ± 0.7 g 845 ± 3 c 610 ± 3 i 1278 ± 3 a 739 ± 2 f 756 ± 9 e 665.6 ± 0.2 h 224 ± 1 l 250 ± 1 k
Notes: nd-not detected; tr-traces. TPA—Total phenolic acids; TF—Total flavonoids; TPC—Total phenolic compounds; Peaks: 1—caffeic acid hexoside; 2—caffeic acid hexoside;
3—p-coumaroyl hexoside; 4—caffeic acid; 5—luteolin-O-hexosyl-O-glucuronide; 6—eriodictyol-O-glucuronide; 7—rosmarinic acid hexoside; 8—luteolin-7-O-glucuronide; 9—sangerinic
acid; 10—rosmarinic acid; 11—lithospermic acid A; 12—methylluteolin-O-glucuronide; 13—salvianolic acid B. Standard calibration curves: caffeic acid (y = 388,345x + 406,369, R2 = 0.994;
LOD = 0.78 µg/mL; LOQ = 1.97 µg/mL) (compounds 1, 2 and 4); p-coumaric acid (y = 301,950x + 6966.7, R2 = 0.999; LOD = 0.68 µg/mL; LOQ = 1.61 µg/mL) (compound 3);
luteolin-7-O-glucoside (y = 4087x + 72,589, R2 = 0.999; LOD = 0.21 µg/mL; LOQ = 0.74 µg/mL) (compounds 5, 8 and 12); hesperetin (y = 34156x + 268,027, R2 = 0.999; LOD = 0.42 µg/mL;
LOQ = 0.87 µg/mL) (compound 6); and rosmarinic acid (y = 191,291x − 652,903, R2 = 0.999; LOD = 0.15 µg/mL; LOQ = 0.68 µg/mL) (compounds 7, 9, 10, 11 and 13). The results were
analyzed using one-way analysis of variance (ANOVA) followed by Tukey’s HSD Test, and in each row and for each extract (hydroethanolic or aqueous extracts) different letters (a to m)
mean significant differences among total compounds (p < 0.05).
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Table 3. Antioxidant activity and anti-inflammatory potential of L. pedunculata hydroethanolic and aqueous extracts (mean ± SD).
1 2 3 4 5 6 7 8 9 10 11 12 13
Hydroethanolic Extracts
Antioxidant Activity (EC50 Values, µg/mL)
DPPH scavenging activity 142 ± 6 ef 139 ± 3 ef 139 ± 2 ef 212 ± 8 b 137 ± 3 f 139 ± 1 f 150 ± 3 d 87 ± 2 g 150 ± 2 d 146 ± 8 de 181 ± 2 c 140 ± 5 ef 257 ± 7 a
Reducing power 110 ± 1 f 98 ± 1 g 117.9 ± 0.5 e 149 ± 2 b 97 ± 2 g 107 ± 2 f 129 ± 1 d 72 ± 1 h 67 ± 1 i 135 ± 9 c 133 ± 3 cd 133 ± 1 cd 216 ± 6 a
β-carotene bleaching
inhibition 1009 ± 88
d 821 ± 34 e 1062 ± 65 d 516 ± 75 f 1176 ± 40 c 1578 ± 77 b 541 ± 43 f 1833 ± 178 a 372 ± 18 g 252 ± 7 h 190 ± 20 h 223 ± 3 h 214 ± 10 h
TBARS inhibition 28 ± 1 g 17 ± 1 i 26 ± 1 h 35 ± 1 e 38.25 ± 0.01 d 63.5 ± 0.1 a 44.56 ± 0.01 c 25.57 ± 0.02 h 38.2 ± 0.3 d 48 ± 2 b 62 ± 4 a 27.7 ± 0.05 gh 31.4 ± 0.1 f
Anti-Inflammatory Potential (EC50 Values, µg/mL)
Nitric oxide (NO) production 190 ± 3 c 198 ± 5 b 190 ± 6 c >400 >400 124 ± 8 f >400 >400 >400 216 ± 12 a 171 ± 3 d 162 ± 4 e >400
Aqueous Extracts
Antioxidant Activity (EC50 Values. µg/mL)
DPPH scavenging activity 109 ± 4 f 99 ± 2 g 99 ± 1 g 68.0 ± 0.5 i 99 ± 2 g 115 ± 1 e 125 ± 2 d 69 ± 3 h 98 ± 3 g 115 ± 2 e 133 ± 3 c 144 ± 6 b 191 ± 2 a
Reducing power 101 ± 2 f 51 ± 1 i 113 ± 4 e 137 ± 4 b 99 ± 2 f 93 ± 3 g 111 ± 2 e 73 ± 1 h 110 ± 2 e 125 ± 4 cd 122 ± 6 d 130 ± 6 c 167 ± 1 a
β-carotene bleaching
inhibition 274 ± 10
f 253 ± 14 fg 267 ± 9 f 385 ± 13 d 472 ± 14 b 475 ± 19 b 422 ± 25 c 388 ± 21 d 452 ± 12 b 236 ± 14 g 305 ± 4 e 391 ± 25 d 530 ± 21 a
TBARS inhibition 14 ± 1 i 24.8 ± 0.4 de 16 ± 1 h 29 ± 1 c 21.8 ± 0.4 fg 22 ± 1 f 21.15 ± 0.01 g 21.2 ± 0.2 g 21 ± 1 g 39.1 ± 0.1 a 25 ± 1 d 24.1 ± 0.4 e 36 ± 1 b
Anti-Inflammatory Potential (EC50 Values. µg/mL)
Nitric oxide (NO) production >400 >400 >400 301 ± 7 a 237 ± 7 b >400 205 ± 7 c 140 ± 5 d >400 >400 >400 >400 >400
Notes: EC50: Extract concentration corresponding to 50% of antioxidant activity or 0.5 of absorbance in reducing power assay. Trolox (positive control) EC50 values: 41 µg/mL (reducing
power), 42 µg/mL (DPPH scavenging activity), 18 µg/mL (β-carotene bleaching inhibition) and 23 µg/mL (TBARS inhibition). Anti-inflammatory activity is expressed as EC50 values
corresponding to 50% of inhibition of the NO production in comparison with the negative control (100% of NO production). Dexamethasone (positive control) EC50 values: 16 µg/mL.
The results were analyzed using one-way analysis of variance (ANOVA) followed by Tukey’s HSD Test, and in each row different letters (a to i) mean significant differences (p < 0.05).
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2.3. Anti-Inflammatory Activities
The in vitro anti-inflammatory results are present in Table 3. In general, hydroethanolic extracts
revealed more promising anti-inflammatory potential (EC50 values ranging from 216 to 124 µg/mL),
showing lower EC50 values than the aqueous extracts (EC50 values ranging between 140 to 301 µg/mL).
Moreover, there were several samples that did not show anti-inflammatory activity (EC50 > 400 µg/mL),
being the absence of this bioactivity higher for the aqueous samples. The samples that presented this
activity were samples 4 (Bragança), 5 (Arronches. Portalegre), 7 (Nisa, Portalegre), 8 (Ponte de Sôr,
Portalegre), 9 (Évora), and 13 (Bragança) in hydroethanolic extract, and samples 1 (Marvão, Portalegre),
2 (Évora), 3 (Vila Viçosa, Évora), 6 (Portalegre), 9 (Évora), 10 (Castelo de Vide, Portalegre), 11 (Elvas,
Portalegre), 12 (Castelo de Vide, Portalegre), and 13 (Bragança) for the aqueous extracts.
Sample 6 hydroethanolic extract (Portalegre) presented the highest anti-inflammatory potential
(124 µg/mL), while for the aqueous extract, sample 8 (Ponte de Sôr, Portalegre) revealed the
highest efficiency, presenting a concentration of 140 µg/mL. Similarly, Algieri et al. [25] studied the
anti-inflammatory activity of L. stoechas hydromethanolic extract, which also exhibited a significantly
inhibition of carrageenan-induced paw edema in mice. Therefore, the hydroethanolic extracts could
also be considered as a good source of anti-inflammatory molecules.
2.4. Cytotoxicity
Table 4 summarizes the effects of L. pedunculata hydroethanolic and aqueous extracts (infusions)
on the inhibition of the growth of four human tumor cell lines (MCF-7, NCI-H460, HeLa and
HepG2). In this study, it was evident the cytotoxic activity of L. pedunculata in all the cell lines
tested, ranging values between 374–82 µg/mL and 340–34 µg/mL, for aqueous and hydroethanolic
extracts, respectively. Comparing the two types of studied extracts, the aqueous extracts showed
anti-proliferative potential in more samples and in more cell lines, however it was the hydroethanolic
extract that, overall, showed a higher cytotoxic potential, i.e., lower GI50 values (34 µg/mL). Sample 6
(Portalegre) hydroethanolic extract presented the best cytotoxic potential in MCF-7 (values ranged
from 53 to 236 µg/mL) and HepG2 (values between from 34 and 212 µg/mL) cell lines. On the other
hand, sample 12 (Castelo de Vide, Portalegre) showed a higher antiproliferative capacity in NCI-H460
cell line (GI50 values = 119 µg/mL); and sample 10 (Castelo de Vide, Portalegre) showed a lower GI50
value in the HeLa cell line (62 µg/mL). In hydroethanolic extract, sample 6, 12 and 13 (Bragança)
revealed lower antiproliferative capacity in NCI-H460 (340 µg/mL), MCF-7 (236 µg/mL) and HeLa
(222 µg/mL) cell lines, respectively; in HepG2 cell line were samples 7 (Nisa, Portalegre) and 13 that
evidenced a lower, with GI50 values of 212 and 204 µg/mL, respectively.
On the other hand, the aqueous extract of sample 9 (Évora) revealed a better cytotoxic potential
in MCF-7 and HepG2 cell lines, with values of 150 and 118 µg/mL, respectively. In the NCI-H460
cell line, the values ranged from 374 and 113 µg/mL, highlighting sample 4 (Bragança) with the
highest antiproliferative activity. Meanwhile, for HeLa cell line, sample 12 (Castelo de Vide, Portalegre)
showed the lowest GI50 value (82 µg/mL).
The cytotoxicity in non-tumor cells were tested using a primary culture cell line obtained from
porcine liver (PLP2 cell culture) and was used as a preliminary toxicity model for normal cells. None
of the samples showed toxicity (GI50 > 400 µg/mL), with the exception of hydroethanolic extract of
sample 12 (Castelo de Vide, Portalegre), and aqueous extracts of sample 7 (Nisa, Portalegre), 8 (Ponte
de Sôr, Portalegre) and 9 (Évora). However, the presented concentrations are much higher than those
obtained for the antiproliferative inhibition using the studied tumor cell lines.
Despite being the same plant species, it is normal the existence of different results.
The geographical origin of the seeds is one of the factors that can directly influence the chemical
and nutritional composition of plants due to biotic and abiotic factors [11], thus, in this case, as the
seeds were harvested from different areas, this factor could lead to the observed oscillations in the
bioactive potential.
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Table 4. Cytotoxic properties of L. pedunculata hydroethanolic and aqueous extracts (mean ± SD).
1 2 3 4 5 6 7 8 9 10 11 12 13
Hydroethanolic Extracts
Tumor Cell Lines (GI50 Values, µg/mL)
MCF-7 61 ± 2 f 57 ± 3 fg 58 ± 2 fg 115 ± 9 c 82 ± 8 d 53 ± 5 g 70 ± 2 e 61 ± 4 f 60 ± 4 f 53 ± 3 g 61 ± 3 f 236 ± 8 a 212 ± 1 b
NCI-H460 285 ± 22 bc 275 ± 22 c 277 ± 10 c >400 >400 340 ± 21 a >400 >400 >400 >400 297 ± 6 b 119 ± 7 e 241 ± 23 d
HeLa 70 ± 5 de 65.0 ± 0.2 fgh 69 ± 2 def 200 ± 14 c 216 ± 7 b 66.2 ± 0.2 efgh 67 ± 2 efgh 63.3 ± 0.1 gh 73.1 ± 0.3 d 62.2 ± 0.6 h 65 ± 2 fgh 68 ± 3 efg 222 ± 6 a
HepG2 82 ± 4 e 67 ± 1 f 94 ± 6 d 144 ± 10 c 191 ± 16 b 34 ± 3 g 212 ± 19 a 67 ± 10 f 100 ± 3 d 62 ± 5 f 65 ± 1 f 203 ± 14 a 204 ± 4 a
Non-Tumor Cells (GI50 Values, µg/mL)
PLP2 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 291 ± 11 >400
Aqueous Extracts
Tumor Cell Lines (GI50 Values, µg/mL)
MCF-7 >400 270 ± 14 c 267 ± 2 c 287 ± 8 b 267.7 ± 0.3 c 222 ± 14 e 223 ± 6 e 185 ± 16 g 150 ± 9 h 290 ± 12 b 256.2 ± 0.6 d 270 ± 14 f 342 ± 14 a
NCI-H460 329 ± 15 c 256 ± 5 e 334 ± 15 c 113 ± 9 i 142 ± 12 h 226 ± 14 f 188 ± 12 g 183 ± 11 g 258 ± 14 e 245 ± 13 e 349 ± 5 b 293 ± 12 d 374 ± 7 a
HeLa >400 >400 310.2 ± 0.4 b 343.92 ± 0.01 a 253 ± 23 d 262 ± 14 d 199 ± 12 f 159 ± 16 g 286 ± 4 c 195 ± 11 f 224 ± 11 e 82 ± 14 h 298 ± 17 bc
HepG2 315 ± 6 a 254 ± 14 c 251 ± 14 c 293 ± 10 b >400 211 ± 17 d 194 ± 15 e 179 ± 14 f 118 ± 8 h 256 ± 4 c 191 ± 143 ef 148 ± 1 g 324 ± 6 a
Non-Tumor Cells (GI50 Values, µg/mL)
PLP2 >400 >400 >400 >400 >400 >400 349 ± 12 b 362 ± 21 a 240 ± 16 c >400 >400 >400 >400
MCF-7: breast carcinoma; NCI-H460: non-small lung cancer; HeLa: cervical carcinoma; HepG2: hepatocellular carcinoma; GI50 values—concentration that inhibited 50% of the net cell
growth. Ellipticine (positive control) GI50 values: 1.21 µg/mL (MCF-7), 1.03 µg/mL (NCI-H460), 0.91 µg/mL (HeLa), 1.10 µg/mL (HepG2) and 2.29 µg/mL (PLP2). The results were
analyzed using one-way analysis of variance (ANOVA) followed by Tukey’s HSD Test, and in each row different letters (a to h) mean significant differences (p < 0.05).
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There are few cytotoxicity studies carried out using this species, however the results described in
literature revealed lower cytotoxic potential, when compared to our results. According to Pereira et
al. [15], the results obtained with L. pedunculata methanolic extracts suggest that for concentrations up
to 15 µg/mL and an incubation period of 24 h, no relevant cytotoxic effects were observed. Tang et
al. [26], tested five human tumor cell lines (NB4, A549, SHSY5Y, PC3, and MCF7) using the methanolic
extract of L. angustifolia, showed a weak inhibitory activity against the tested human tumor cell lines
(IC50 values ranging from 2.2–8.2 mM).
2.5. Antimicrobial Activity
The results on antibacterial and antifungal activities of L. pedunculata hydroethanolic and aqueous
extracts are presented in Table 5. The samples were tested against a panel of eight bacteria and fungi
strains, specifically selected on the basis of their importance to public health.
Table 5. Antibacterial (MIC and MBC, µg/mL) and antifungal (MIC and MFC, µg/mL) activities of L.
pedunculata hydroethanolic and aqueous extracts.
Antibacterial Activity
Hydroethanolic Extracts
1 2 3 4 5 6 7 8 9 10 11 12 13 S A
MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC
MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC
B.c.
50 75 75 75 50 75 75 75 75 75 75 75 200 100 250
75 150 150 150 75 150 150 150 150 150 150 150 300 200 400
M.f.
75 100 100 100 75 100 100 100 100 100 100 300 200 200 250
150 150 150 150 150 150 150 150 150 150 150 450 300 300 400
S.a.
20 40 30 150 100 150 150 150 200 150 200 450 200 40 250
40 75 40 300 150 300 300 300 150 300 300 600 300 100 450
L.m.
100 150 100 150 100 150 150 150 150 150 200 450 200 200 400
150 300 150 300 150 300 300 300 300 300 300 600 300 300 500
E.c.
75 100 100 100 75 100 100 100 100 100 100 200 450 200 400
150 150 150 150 150 150 150 150 150 150 150 300 600 300 500
En.cl.
40 40 40 50 40 40 100 75 75 75 75 200 450 200 250
75 75 75 75 75 75 150 150 150 150 150 300 600 300 500
P.a.
100 150 100 150 100 150 150 150 150 150 150 300 150 200 750
150 300 150 300 150 300 300 300 300 300 300 450 300 300 1200
S.t.
150 150 150 200 100 200 200 150 200 200 200 150 150 250 400
300 300 300 300 150 300 300 300 300 300 300 300 300 500 750
Aqueous Extracts
1 2 3 4 5 6 7 8 9 10 11 12 13 S A
MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC
MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC MBC
B.c.
200 300 150 300 75 200 150 200 150 150 150 300 150 100 250
300 450 300 450 150 300 300 300 300 300 300 450 300 200 400
M.f.
200 300 200 300 200 300 200 200 200 150 200 450 200 200 250
300 450 300 450 300 450 300 300 300 300 300 600 300 300 400
S.a.
300 300 300 300 450 300 200 200 150 300 300 300 300 40 250
450 450 600 450 600 450 300 300 300 450 450 600 600 100 450
L.m.
300 300 300 300 450 300 300 300 150 300 300 300 300 200 400
600 600 600 600 600 450 450 450 300 450 450 600 600 300 500
E.c.
200 200 200 200 200 200 200 100 200 450 200 450 200 200 40
300 300 300 300 300 300 300 150 300 600 300 900 300 300 500
En.cl.
150 200 200 200 200 150 200 150 150 200 150 200 150 200 250
300 300 300 300 300 300 300 300 300 300 300 300 300 300 500
P.a.
300 450 300 300 300 300 300 150 150 300 300 300 300 200 750
450 600 600 600 600 450 600 450 300 450 600 600 600 300 1200
S.t.
450 450 300 300 300 300 300 300 150 300 300 300 300 250 400
600 600 600 600 600 600 600 450 300 450 600 600 600 500 750
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Table 5. Cont.
Antifungal Activity
Hydroethanolic Extracts
1 2 3 4 5 6 7 8 9 10 11 12 13 K B
MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC
MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC
A.fum.
75 150 75 75 100 40 150 75 100 150 150 200 200 250 150
150 300 150 150 150 75 300 150 150 300 300 300 300 500 200
A.v.
40 30 40 40 75 40 40 40 75 150 75 150 150 200 100
75 75 150 75 150 75 75 75 150 300 150 300 300 500 200
A.o.
40 40 50 40 75 40 50 40 20 75 40 100 200 150 150
75 75 75 75 150 75 75 100 40 150 75 300 300 2000 200
A.n.
50 75 40 75 150 75 150 75 150 150 200 150 200 200 150
75 150 75 150 300 150 300 150 300 300 300 300 300 500 200
T.v.
20 40 20 30 75 30 30 50 15 50 30 75 100 1000 150
40 75 40 40 150 40 40 75 20 75 40 150 150 1000 200
P.f.
75 75 40 75 200 75 75 40 75 75 150 200 200 200 200
150 150 75 150 300 15 150 75 150 150 300 300 300 500 250
P.o.
40 40 30 40 100 40 40 150 40 75 75 30 30 2500 200
75 75 40 75 150 75 75 200 75 150 150 450 450 3500 250
P.v.c.
75 150 50 100 200 75 150 150 150 150 150 300 300 200 100
150 300 75 150 300 150 300 300 300 300 300 450 450 300 200
Aqueous Extracts
1 2 3 4 5 6 7 8 9 10 11 12 13 K B
MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC
MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC MFC
A.fum.
300 300 600 - 600 300 - - 600 600 300 300 450 250 150
600 600 1200 - 1200 600 - - 900 1200 450 600 900 500 200
A.v.
300 300 300 600 300 300 300 300 300 200 100 150 200 200 100
600 600 600 1200 600 600 600 600 600 450 200 300 300 500 200
A.o.
600 900 - - - 600 300 - 200 300 150 300 200 1500 150
1200 1200 - - - 1200 600 - 450 600 300 450 450 2000 200
A.n.
- 300 - - - 600 - - 300 - 200 450 450 200 150
- 600 - - - 1200 - - 450 - 450 900 900 500 200
T.v.
600 300 600 600 - 600 - - 100 300 200 450 450 1000 150
1200 600 1200 1200 - 1200 - - 300 600 450 600 600 1000 200
P.f.
600 300 600 - 600 - - - - - 450 450 450 200 200
1200 600 1200 - 1200 - - - - - 600 900 900 500 250
P.o.
900 450 600 - 600 - - - 200 - 450 450 450 2500 200
1200 600 1200 - 1200 - - - 450 - 600 900 900 3.50 0.25
P.v.c.
- 600 600 - - - - - 200 450 450 450 450 200 100
- 1200 1200 - - - - - 450 900 600 900 900 300 200
Notes: MIC: Minimal Inhibitory Concentration; MBC: Minimal Bactericidal Concentration; MFC: Minimal Fungicide
Concentration; S: Streptomycin; A: Ampicillin; K: Ketoconazole; B: Bifonazole; B.c.: Bacillus cereus; M.f.: Micrococcus
flavus; S.a.: Staphylococcus aureus; L.m.: Listeria monocytogenes; E.c.: Escherichia coli; En. cl.: Enterobacter cloacae; P.a.:
Pseudomonas aeruginosa; S.t.: Salmonella typhimirium; A.fum.: Aspergillus fumigatus; A.v.: Aspergillus versicolor; A.o.:
Aspergillus ochraceus; A.n.: Aspergillus niger; T.v.: Trichoderma viride; P.f.: Penicillium funiculosum; P.o.: Penicillium
ochrochloron; P.v.c.: Penicillium verrucosum var. cyclopium.
For antibacterial activity of the hydroethanolic extracts, samples 1 (Marvão, Portalegre) and 5
(Arronches, Portalegre) revealed a higher activity (lower MICs) for all the studied strains. In these
cases, MIC values range from 20 µg/mL in sample 1 for the Staphylococcus aureus strain and 40 µg/mL
in sample 5 for the Enterobacter cloacae strain. The lowest MBC values were observed for samples 1 and
3 (Vila Viçosa, Évora) in the inhibition of Staphylococcus aureus strain (40 µg/mL). In the evaluation
of L. pedunculata aqueous extracts, sample 5 showed the lowest MIC and MBC, being more potent
for Bacillus cereus strain (MIC = 75 µg/mL and MBC = 150 µg/mL), along with the MBC of sample 8
(Ponte de Sôr, Portalegre) in Escherichia coli strain (also 150 µg/mL). These results are in agreement
with previous studies, where other plants species also showed antimicrobial activity: for example,
Castanea sativa Mill. flowers [27], Alnus rugosa L. aerial parts [28], and Veronica urticifolia Jacq. [29].
Nikolic et al. [30] studied the essential oils of different Thymus species, such as T. serpyllum, T. algeriensis
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and T. vulgaris, which showed antimicrobial activity. However, to the best of the author’s’ knowledge
there are no studies reporting the antibacterial activity of the studied Lavandula species.
Considering the antifungal activity, for hydroethanolic extracts, all samples revealed inhibitory
and fungicidal activity. Sample 3 showed the best MIC values for all the tested strains, with the
exception of Aspergillus versicolor and Aspergillus ochraceus, where samples 2 and 9 revealed the highest
potential, respectively. Regarding the MFC, in general, most of the samples revealed promising results,
being better for sample 13 aqueous extract. In the case of aqueous extracts, only a few samples showed
activity in all the studied strains, meanwhile samples 2, 11, 12 and 13 showed inhibitory and fungicidal
potential for all the studied fungi strains. Samples 9 and 11 presented the highest inhibitory capacity
for all the fungal strains analysed. The best fungicide capacity was evident in sample 11 against
Aspergillus versicolor strain.
The antifungal potential is, also, in agreement with other studies regarding antifungal activity of
other plant species, which were carried out by other authors, such as Castanea sativa [27] and Alnus
rugosa [28]. Once more, to the best of the authors’ knowledge, there are no previous studies on the
antifungal activity of L. pedunculata.
3. Materials and Methods
3.1. Samples and Samples Preparation
The studied samples concern plant materials (the top 20 cm of the flowering stems with
inflorescences) randomly harvested in each of thirteen field plots of Lavandula pedunculata (Mill.) Cav.
(botanical family Lamiaceae) grown at the Portuguese Genebank (Banco Português de Germoplasma
Vegetal, BPGV).
The Portuguese Genebank conserves ex situ, using cold temperatures (e.g., 5–6 ◦C), a collection of
medicinal and aromatic plants, including species of the genus Lavandula. The col, lection consists of
seed samples (accessions) of wild specimens that have been randomly collected in different natural
populations within several Portuguese regions [8].
For this study, the stored seeds of thirteen accessions of L. pedunculata, of the BPGV collection
were sown and the plantlets transplanted outdoor to thirteen field plots, in BPGV farm at S. Pedro de
Merelim, Braga, Northern Portugal (GPS coordinates 41◦34’28.01” N; 8◦27’09.21” S).
In 2015, the flowering parts in blossom of each accession grown were harvested, kept in paper
bags at −20 ◦C, corresponding individually to a sample. Each sample of plant material (approximately
200 g) was subsequently lyophilized (FreeZone 4.5, Labconco, Kansas City, MO, USA), reduced to a
fine dried powder (~20 mesh) and mixed to obtain a homogenate sample, corresponding to a total of
thirteen different samples.
The thirteen studied accessions of L. pedunculata were gathered wild in two Portuguese regions,
Alentejo and Trás-os-Montes (Table 6), altitude range between 100 and 1000 m [8]. This species
has several synonymies such as Lavandula eliasii Sennen, Lavandula pedunculata subsp. pedunculata,
Lavandula stoechas subsp. pedunculata (Mill.) Samp. ex Rozeira, Lavandula stoechas subsp. lusitanica
(Chaytor) Rozeira, and Stoechas pedunculata Mill. [9].
The hydroethanolic extracts were obtained from the lyophilized plant material. The dried
sample was extracted following a procedure previously described by Pereira et al. [31]. A solution of
ethanol/water (80:20 v/v) (25 mL) was added to 1 g of sample and stirring for 1 h (25 ◦C at 150 rpm)
and subsequently filtered through Whatman No. 4 paper. The residue was then re-extracted with
an additional portion of 25 mL of the same solution (25 ◦C at 150 rpm) during 1 h. The combined
extracts were evaporated to remove the ethanolic fraction (at 40 ◦C) and then the water was frozen
and lyophilized.
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Table 6. Geographical information about the studied L. pedunculata samples.
Samples BPGV Accession Number Origin Site Data Altitude (m)
1 10378 Marvão. Portalegre 333
2 09845 Évora 198
3 09838 Vila Viçosa. Évora 420
4 11290 Bragança 810
5 10372 Arronches. Portalegre 375
6 10400 Portalegre 375
7 10418 Nisa. Portalegre 291
8 10387 Ponte de Sôr. Portalegre 175
9 10391 Évora 155
10 10412 Castelo de Vide. Portalegre 358
11 10369 Elvas. Portalegre 267
12 10379 Castelo de Vide. Portalegre 353
13 11308 Bragança 667
More information in Lopes and Barata [9]; Accessions passport data documented and available at Grin-Global
database (http://bpgv.iniav.pt).
The aqueous extracts (infusions) preparation was established according a study performed by
Pereira et al. [31]. Powdered samples (2 g) were added to 200 mL of boiling distilled water, left to stand
at room temperature for 5 min, and then filtered under reduced pressure, frozen and lyophilized.
3.2. Standards and Reagents
Acetonitrile 99.9% was of HPLC grade from Fisher Scientific (Lisbon, Portugal). Phenolic compound
standards (caffeic acid≥ 99%, p-coumaric acid ≥ 90%; hesperetin ≥ 99%, luteolin-7-O-glucoside ≥ 99%,
quercetin-3-O-glucoside ≥ 99%, rosmarinic acid ≥ 99% HPLC purity) were from Extrasynthese (Genay,
France). Trypan blue, lipopolysaccharide (LPS), dexamethasone, acetic acid, formic acid, ellipticine,
sulforhodamine B (SRB), trichloroacetic acid (TCA) and Tris were all purchased from Sigma-Aldrich
(St. Louis, MO, USA). Dulbecco’s modified Eagle’s medium was purchased from HyClone. RAW264.7
cells were acquired from ECACC (“European Collection of Animal Cell Culture”) (Salisburg, UK), Griess
reagent system kit was purchased from Promega, Fetal bovine serum (FBS), L-glutamine, Hank’s balanced
salt solution (HBSS), trypsin-EDTA (ethylenediaminetetraacetic acid), penicillin/streptomycin solution
(100 U/mL and 100 mg/mL, respectively), RPMI-1640 and DMEM media were from Hyclone (Logan,
UT, USA). Water was treated in Milli-Q water purification system (TGI Pure Water Systems, Greenville,
SC, USA).
3.3. Analysis of Phenolic Compounds
The lyophilized extracts were re-dissolved at 5 mg/mL in ethanol/water (20:80, v/v) and 100% water
for hydroethanolic and aqueous extract, respectively, and filtered through a 0.22-µm disposable LC filter
disk. Chromatographic analyses were performed in a Dionex Ultimate 3000 UPLC (Thermo Scientific,
San Jose, CA, USA) system equipped with a diode array detector (DAD) coupled to an electrospray
ionization mass detector (LC-DAD-ESI/MSn) as previously described by Bessada et al. [32].
Chromatographic separation was achieved with a Waters Spherisorb S3 ODS-2 C18 (3 µm,
4.6 mm × 150 mm, Waters, Milford, MA, USA) column thermostatted at 35 ◦C. The solvents used
were: (A) 0.1% formic acid in water; (B) acetonitrile (HPLC purity). The elution gradient established
was isocratic 15% B (5 min), 15% B to 20% B (5 min), 20-25% B (10 min), 25–35% B (10 min), 35–50% B
(10 min), and re-equilibration of the column, using a flow rate of 0.5 mL/min. Double online detection
was carried out in the DAD using 280, 330, 370 and 520 nm as preferred wavelengths and in a mass
spectrometer (MS) connected to HPLC system via the DAD cell outlet.
MS detection was performed in negative mode, using a Linear Ion Trap LTQ XL mass spectrometer
(Thermo Finnigan, San Jose, CA, USA) equipped with an ESI source. Nitrogen served as the sheath
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gas (50 psi); the system was operated with a spray voltage of 5 kV, a source temperature of 325 ◦C,
a capillary voltage of −20 V. The tube lens offset was kept at a voltage of −66 V. The full scan covered
the mass range from m/z 100 to 1500. The collision energy used was 35 (arbitrary units). Data
acquisition was carried out with Xcalibur® data system (Thermo Finnigan, San Jose, CA, USA).
Compounds were carefully identified comparing the obtained information: retention times,
UV-vis and mass spectra, with those obtained from standard compounds, when available. Otherwise,
compounds were tentatively identified comparing the obtained information with available data
reported in the literature. For the quantification, a calibration curve was constructed for each available
phenolic standard based on the UV signal (maximum absorption of each standard compound lambda
max). When a commercial standard was not available, the quantification was performed through the
calibration curve of the most similar available standard. The results were expressed as mg/g of extract.
3.4. Evaluation of the Antioxidant Activity
The lyophilized extracts were re-dissolved in ethanol/water (80:20 v/v) and water for
hydroethanolic and aqueous extracts, respectively (final concentration 10 mg/mL), and submitted to
various in vitro colorimetric assays (DPPH radical-scavenging activity, reducing power, inhibition of
β-carotene bleaching and inhibition of lipid peroxidation—TBARS).
DPPH radical-scavenging activity was performed using an ELX800 Microplate Reader (Bio-Tek).
The reaction mixture in each one of the 96-wells consisted of one of the different concentrations of
the extracts (30 µL) and the methanolic solution containing DPPH radicals (6 × 10−5 mol/L, 270 µL).
The mixture was left to stand for 60 min in the dark. The reduction of the DPPH radical was determined
by measuring the absorption at 515 nm. The radical scavenging activity (RSA) was calculated by
the equation: % RSA = [(ADPPH − AS)/ADPPH] × 100 (AS is the absorbance of the solution when the
sample extract has been added at a particular level and ADPPH is the absorbance of the DPPH solution).
The extract concentration providing 50% of the radicals scavenging activity (EC50) was calculated from
the graph of RSA percentage against extract concentration.
Reducing power evaluation was performed using the Microplate Reader cited above. The different
concentrations of the extracts (0.5 mL) were mixed with sodium phosphate buffer (200 mmol/L, pH
6.6, 0.5 mL) and potassium ferricyanide (1% w/v, 0.5 mL). For each concentration, the mixture was
incubated at 50 ◦C during 20 min, and then was added trichloroacetic acid (10% w/v, 0.5 mL).
The mixture (0.8 mL) was poured in the 48-wells, as were deionized water (0.8 mL) and ferric
chloride (0.1% w/v, 0.16 mL), and was measured the absorbance at 690 nm. The extract concentration
providing 0.5 of absorbance (EC50) was calculated from the graph of absorbance at 690 nm against
extract concentrations.
In inhibition of β-carotene bleaching, a solution of β-carotene was previously prepared dissolving
β-carotene (2 mg) in chloroform (10 mL) and 2 mL of this solution were pipetted into a round-bottom
flask. After chloroform removed (at 40 ◦C under vacuum) linoleic acid (40 mg), Tween 80 emulsifier
(400 mg), and distilled water (100 mL) were added with vigorous shaking. Aliquots (4.8 mL) of
this emulsion were transferred into different tubes containing different concentrations of the extracts
(0.2 mL). The tubes were shaken and incubated (at 50 ◦C) in a water bath. As soon as the emulsion was
added to each tube, the zero-time absorbance was measured at 470 nm. β-carotene bleaching inhibition
was calculated using the equation: β-carotene content after 2 h of assay/initial β-carotene content) × 100.
The extract concentration providing 50% antioxidant activity (EC50) was calculated by interpolation
from the graph of β-carotene bleaching inhibition percentage against extract concentration.
Lipid peroxidation inhibition was evaluated using a porcine (Sus scrofa) brains (obtained from
official slaugh-tered animals). This is homogenized with Polytron in an ice-cold Tris–HCl buffer
(20 mM, pH 7.4) to produce a 1:2, w/v brain tissue homogenate which was centrifuged (3000× g;
10 min). Analiquot (100 µL) of the supernatant was incubated with the sample solutions (200 µL) in the
presence of FeSO4 (10 mM; 100 µL) and ascorbic acid (0.1 mM; 100 µL) at 37 ◦C during 1 h. The reaction
was stopped by the addition of trichloroacetic acid (28%, w/v, 500 µL), and then thiobarbituric acid
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(TBA, 2%, w/v, 380 µL). The mixture was then heated at 80 ◦C during 20 min. After centrifugation
(3000× g; 10 min), the color intensity of the malondialdehyde (MDA)–TBA complex in the supernatant
was measured (at 532 nm). The inhibition ratio (%) was calculated using the formula: inhibition ratio
(%) = [(A − B)/A] × 100% (A were the absorbance of the control and B were the absorbance of sample
solution). The extract concentration providing 50% of antioxidant activity (EC50) was calculated from
the graph of TBARS formation inhibition against extract concentrations.
All the results were expressed in EC50 values (µg/mL) and trolox was used as positive control [33].
3.5. Evaluation of the Cytotoxicity
3.5.1. General
For cytotoxicity evaluation all lyophilized extracts were re-dissolved in water, with a final solution
of 8 mg/mL and diluted to different concentrations. The assay was performed according a procedure
described by Guimarães et al. [34]. Ellipticine was used as positive control and the results were
calculated as GI50 values (sample concentration that inhibited 50% of the net cell growth).
3.5.2. In Tumor Cell Lines
Four human tumor cell lines were used to acee the cytotoxicity evaluation: MCF-7 (breast
adenocarcinoma), NCI-H460 (non-small cell lung cancer), HeLa (cervical carcinoma) and HepG2
(hepatocellular carcinoma). Cells were routinely maintained as adherent cell cultures in RPMI-1640
medium containing 10% heat-inactivated FBS (MCF-7, NCI-H460 and HCT-15) and 2 mM glutamine
or in DMEM supplemented with 10% FBS, 2 mM glutamine, 100 U/mL penicillin and 100 mg/mL
streptomycin (HeLa and HepG2 cells), at 37 ◦C, in a humidified air incubator containing 5% CO2.
The cell lines were plated an appropriate density (1.0 × 104 cells/well) in 96-well plates and allowed
to attach for 24 h. Cells were then treated for 48 h with several extract concentrations. Following
this incubation period, the adherent cells were fixed by adding cold 10% trichloroacetic acid (TCA,
100 µL) and incubated during 60 min at 4 ◦C. Plates were then washed with deionized water and
dried; sulforhodamine B solution (0.1% in 1% acetic acid, 100 µL) was then added to each plate well
and incubated during 30 min at room temperature. Unbound SRB was removed by washing with 1%
acetic acid. Plates were air-dried, the bound SRB was solubilized with 10 mM Tris (200 µL) and the
absorbance was measured at 540 nm in the microplate reader cited above. The results were expressed
in GI50 values; sample concentration that inhibited 50% of the net cell growth [34].
3.5.3. In Non-Tumor Cells
For the hepatotoxicity evaluation, a cell culture was prepared from a freshly harvested porcine
liver obtained from a local slaughter house, and it was designed as PLP2. Briefly, the liver tissues were
rinsed in hank’s balanced salt solution containing 100 U/mL penicillin, 100 µg/mL streptomycin and
divided into 1 × 1 mm3 explants. Some of these explants were placed in 25 cm2 tissue flasks in DMEM
medium supplemented with 10% fetal bovine serum, 2 mM nonessential amino acids and 100 U/mL
penicillin, 100 mg/mL streptomycin and incubated at 37 ◦C with a humidified atmosphere containing
5% CO2. The medium was changed every two days. Cultivation of the cells was continued with direct
monitoring every two to three days using a phase contrast microscope. Before confluence was reached,
cells were subcultured and plated in 96-well plates at a density of 1.0 × 104 cells/well, and cultivated
in DMEM medium with 10% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin [34].
3.6. Evaluation of the Anti-Inflammatory Activity
For the cells treatment, the mouse macrophage-like cell line RAW 264.7 was cultured in DMEM
medium supplemented with 10% heat-inactivated fetal bovine serum, glutamine and antibiotics at
37 ◦C under 5% CO2, in humidified air. For each experiment, cells were detached with a cell scraper.
In the experiment cell density of 5 × 105 cells/mL was used, and the proportion of dead cells was
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less than 5% according to the Trypan blue dye exclusion test. Cells were seeded in 96-well plates
at 150,000 cells/well and allowed do attach to the plate overnight. Subsequently, cells were treated
with the several concentrations of each extract during 1 h. Dexamethasone (50 µM) was used as a
positive control for the experiment. The following step was the stimulation with LPS (1 µg/mL) for
18 h. The effect of all the tested samples in the absence of LPS was also analyzed, to observe if they
induced changes in Nitric oxide (NO) basal levels. In negative controls, no LPS was added. Both
extracts and LPS were dissolved in supplemented DMEM.
Anti-inflammatory assay was performed in concentration range 400–125 µg/mL and
dexamethasone (50 µM) was used as a positive control. The mouse macrophage-like cell line RAW
264.7 stimulated with LPS was used in the assay. Nitric oxide (NO) production was studied with Griess
Reagent System kit. Results were expressed as EC50 values (µg/mL) equal to the sample concentration
providing a 50% inhibition of NO production [35].
3.7. Evaluation of the Antimicrobial Activity
3.7.1. Antibacterial Activity
Escherichia coli (ATCC (American type culture collection) 35210), Enterobacter cloacae (ATCC 35030),
Salmonella typhimurium (ATCC 13311), and Pseudomonas aeruginosa (ATCC 27853), were the used
Gram-negative bacteria used, while Listeria monocytogenes (NCTC (National collection of type cultures)
7973), Micrococcus flavus (ATCC 10240), Bacillus cereus (clinical isolate), Staphylococcus aureus (ATCC
6538), were the used Gram-positive bacteria. The minimum inhibitory (MIC) and minimum bactericidal
(MBC) concentrations were determined by the microdilution method. Each fresh overnight culture
of bacteria was adjusted spectrophotometrically (625 nm) to a concentration of 1 × 105 CFU/mL.
Dilutions of inocula were cultured on solid medium to verify the absence of contamination and check
the validity of each inoculum. Different dilutions of the aqueous extract were added to the wells
containing 100 µL of Tryptic Soy Broth (TSB) and afterwards, 10 µL of inoculum was added to all wells.
The microplates were incubated for 24 h at 37 ◦C. The MIC of the samples was detected following
the addition of 40 µL of iodonitrotetrazolium chloride (INT) (0.2 mg/mL) and incubation at 37 ◦C for
30 min. The lowest concentration that produced a significant inhibition (around 50%) of the growth of
the bacteria in comparison with the positive control was identified as the MIC. MICs, obtained from
the susceptibility testing of various bacteria to tested extracts were determined also by a colorimetric
microbial viability assay based on the reduction of the INT colour and compared with a positive control
for each bacterial strain. MBC were determined by serial sub-cultivation of 10 µL into microplates
containing 100 µL of TSB. The lowest concentration that showed no growth after this sub-culturing
was read as the MBC [36]. The results were expressed in mg/mL.
3.7.2. Antifungal Activity
Aspergillus ochraceus (ATCC 12066), Aspergillus versicolor (ATCC 11730), Aspergillus niger (ATCC
6275), Aspergillus fumigatus (ATCC 1022), Trichoderma viride (IAM (Culture Collection, Center for
Cellular and Molecular Research, Institute of Molecular and Cellular Biosciences, The University of
Tokyo, Japan) 5061), Penicillium funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC 9112) and
Penicillium verrucosum var. cyclopium (food isolate) were used. Fungal spores were washed from the
surface of agar plates with sterile 0.85% saline containing 0.1% Tween 80 (v/v). The spore suspension
was adjusted with sterile saline to a concentration of approximately 1.0 × 105 in a final volume of
100 µL per well. The inocula were stored at 4 ◦C for further use. Dilutions of each inoculum were
cultured on solid MA to verify the absence of contamination and to check the validity of the inoculum.
MIC determination was also performed by a serial dilution technique using 96-well microtitre plates.
The investigated sample was dissolved in water and added to broth malt medium with a fungal
inoculum. The microplates were incubated during 72 h at 28 ◦C. The lowest concentrations without
visible growth (as assessed using a binocular microscope) were defined as the MICs. The minimum
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bactericidal and fungicidal concentrations (MBC and MFC) were determined by serial sub-cultivation
of 2 µL in microtitre plates containing 100 µL of malt broth per well and further incubation for 72 h
at 28 ◦C. The lowest concentration with no visible growth was defined as the MFC, indicating 99.5%
killing of the original inoculum. Streptomycin and ampicillin, bifonazole and ketoconazole (in a range
of 0.01 to 5 mg/mL) were used as positive controls and for negative control 5% DMSO was used [36].
The results were expressed in µg/mL.
3.8. Statistical Analysis
In this study all the assays were carried out in triplicate. The results are expressed as mean values
and standard deviation (SD). All results were analyzed using one-way analysis of variance (ANOVA)
followed by Tukey’s HSD Test with α = 0.05. These analyses were carried out using IBM SPSS Statistics,
Version 23.0. (IBM Corp., Armonk, New York, USA).
4. Conclusions
Overall, the study of natural matrices allows a greater knowledge of their chemical composition
and, therefore, a more adequate applicability. The present study allowed to deep knowledge on the
phenolic profile of L. pedunculata, since samples with different origins were studied. In general, most of
the samples revealed diverse bioactive properties, such as, cytotoxicity, antioxidant, anti-inflammatory
and antimicrobial activity. The aqueous extracts showed a higher concentration of phenolic compounds
and a higher antioxidant activity; nevertheless, the hydroethanolic extracts exhibited a higher
anti-inflammatory potential in most of the samples, as also a higher antiproliferative capacity and
antimicrobial activity. This may be due to the fact that hydroethanolic extracts contains other
compounds (non-phenolic compounds), which could be correlated with these bioactivities.
Besides the great importance of L. pedunculata bioactive properties, these results also highlight the
existing variances between samples from different geographical origin. Further studies are required to
correlate biotic and abiotic factors with the chemical composition of the specimens.
The studied plant materials were obtained from previously conserved seeds (accessions) of
different L. pedunculata populations, of the Portuguese Genebank collection. These outcomes
contributed to data on important chemical characteristics, which might distinguish accessions within
a species. Such characterization provides essential information assuring the best utilization of the
conserved germplasm to the final users, meeting the goal of ex situ conservation of germplasm
in genebanks.
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